search
Back to results

Acoustic Stimulation, Sleep, and Cognitive-Emotional Processes in Young Adults With Anxiety and Depression Symptoms (SERS)

Primary Purpose

Acoustic Stimulation

Status
Not yet recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Acoustic Stimulation (STIM)
No Acoustic Stimulation (SHAM)
Daily acoustic stimulation (STIM2)
No daily acoustic stimulation (SHAM2)
Sponsored by
Michelle Stepan
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Acoustic Stimulation focused on measuring Acoustic stimulation, Slow-wave activity, Anxiety, Depression, Cognitive control, Emotion, Daily acoustic stimulation

Eligibility Criteria

18 Years - 25 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Age 18-25. Equal numbers of men and women will be included. Normal hearing. Elevated anxiety or depression symptoms. This will be determined using the PROMIS anxiety and PROMIS depression scales. Participants with T-scores ≥ 60 (i.e., ≥ than 1 standard deviation above the mean) on either or both scales will be eligible for participation. Elevated sleep disturbance. This will be determined using the PROMIS sleep disturbance scale. Participants with T-scores ≥ 55 on the PROMIS sleep disturbance scale will be eligible for participation. Exclusion Criteria: Presence of a severe chronic or psychiatric condition including psychosis, bipolar disorder, developmental disorders, or substance use disorder. Current use of psychotropic medications or medications affecting sleep/wake function, such as antidepressants, antipsychotic medications, steroids, and stimulants. Rationale: These medications may affect sleep and cognitive-emotional function. Substance abuse. Rationale: Substance abuse may affect sleep and cognitive-emotional function. Consumption of > 14 standard alcoholic drinks per week. Rationale: excessive alcohol consumption may interfere with sleep and cognitive-emotional function. Consumption of > 400mg of caffeine per day, which is roughly equivalent to 3-4 8oz cups of coffee per day. Drug or alcohol use < 48 hours before the in-lab overnight sessions. Rationale: Recent drug or alcohol use could affect sleep, cognitive-emotional processes, and poses a safety risk. Severe insomnia or sleep apnea symptoms. Insomnia symptoms will be determined using the Insomnia Severity Index. Participants with severe insomnia (i.e., scores > 21) will not be eligible. Sleep apnea symptoms will be determined using the STOP-Bang questionnaire. Participants with scores ≥ 3 will not be eligible. Rationale: Sleep disturbances which result in low sleep efficiency and frequent awakenings during the night may reduce the effectiveness of acoustic stimulation which targets the deepest stage of sleep (i.e., slow-wave sleep). Extreme bedtimes (< 10:00pm, > 1:00am) or wake times (< 6:00am, > 10:00am). Rationale: Participants with extreme bed or wake times may have difficulty falling asleep, waking up, or obtaining a sufficient amount of sleep during the in-lab overnight sessions. Short (<5hrs) or long (>9hrs) average sleep duration. Rationale: short or long sleepers may have different sleep profiles which could impact the effectiveness of the acoustic stimulation intervention. Uncorrected vision problems. Claustrophobia. Rationale: MRI safety criteria. Metal in body. Rationale: MRI safety criteria. Body Mass Index (BMI) > 40. Rationale: MRI safety criteria. Pregnancy. Rationale: MRI safety criteria. Left handedness. Rationale: Left-handed people may have different lateralization of neural functioning which could affect the fMRI results. Formal vocal training. Rationale: The purpose of the karaoke task is to induce negative self-referential emotions via out-of-tune singing. Good at singing in tune. Rationale: The purpose of the karaoke task is to induce negative self-referential emotions, therefore participants who are good at singing in tune will be excluded. Does not own a smartphone or tablet. Rationale: participants will need to download the Alfin app to download their sleep data from the Dreem 2 headband when wearing the headband at home. Inability or unwillingness to complete study procedures.

Sites / Locations

  • University of Pittsburgh

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Experimental

Experimental

Arm Label

Stim, then Sham, then daily Stim

Stim, then Sham, then daily Sham

Sham, then Stim, then daily Stim

Sham, then Stim, then daily Sham

Arm Description

For the 2 overnights in the sleep lab, this arm will be randomized to complete acoustic stimulation (STIM) on the first overnight and no acoustic stimulation (SHAM) on the second overnight and then daily acoustic stimulation (STIM2) during the ~2 weeks at-home.

For the 2 overnights in the sleep lab, this arm will be randomized to complete acoustic stimulation (STIM) on the first overnight and no acoustic stimulation (SHAM) on the second overnight and then no daily acoustic stimulation (SHAM2) during the ~2 weeks at-home.

For the 2 overnights in the sleep lab, this arm will be randomized to complete no acoustic stimulation (SHAM) on the first overnight and acoustic stimulation (STIM) on the second overnight and then daily acoustic stimulation (STIM2) during the ~2 weeks at-home.

For the 2 overnights in the sleep lab, this arm will be randomized to complete no acoustic stimulation (SHAM) on the first overnight and acoustic stimulation (STIM) on the second overnight and then no daily acoustic stimulation (SHAM2) during the ~2 weeks at-home.

Outcomes

Primary Outcome Measures

Acute change in slow-wave activity
Change in 0.5 - 4 Hz delta spectral power
Slow-wave activity (chronic change)
0.5 - 4 Hz delta spectral power
Change in top-down attention d'
Change in the standardized hit rate for AX trials minus the standardized false alarm rate to AY trials on the modified AX-CPT task
Change in cognitive flexibility d'
Change in the standardized hit rate for BY trials minus the standardized false alarm rate to AX trials on the modified AX-CPT task
Change in frontoparietal cognitive control circuit activity
Change in fMRI activity in the frontoparietal cognitive control circuit activity (e.g., dorsolateral prefrontal cortex, inferior parietal lobule, middle cingulate gyrus, precuneus) for the AX v. AY contrast during the modified AX-CPT task
Change in frontoparietal cognitive control circuit activity
Change in fMRI activity in the frontoparietal cognitive control circuit activity (e.g., dorsolateral prefrontal cortex, inferior parietal lobule, middle cingulate gyrus, precuneus) for the BY v. AX contrast during the modified AX-CPT task
Change in negative affect
Change in average self-reported negative affect using Likert-style scales during the International Affective Picture Stimuli task. Scales will range from 1-100, with higher scores representing more negative affect.
Change in frontolimbic emotional reactivity circuit activity
Change in fMRI activity in the frontolimbic emotional reactivity circuit activity for the negative v. neutral image contrast during the International Affective Picture Stimuli task
Change in anxiety symptoms
Change in self-reported anxiety using the PROMIS anxiety scale (T-scores range from 36.3-82.7, with higher scores indicating worse anxiety symptoms)
Change in depression symptoms
Change in self-reported depression using the PROMIS depression scale (T-scores range from 37.1-81.1, with higher scores indicating worse depression symptoms)
Change in mood
Change in self-reported mood on the Daytime Insomnia Symptom Scale. All 20 subscales will be assessed and each subscale score ranges from 1-100, with higher scores indicating more of that mood (i.e., alert, sad, tense, effort, happy, weary, calm, sleep, overall mood, clear-headed, fatigued, anxious, exhausted, relaxed, forgetful, efficient, stressed, energetic, irritable, ability to concentrate).
Change in anxiety/depression symptoms
Change in self-reported anxiety and depression using the Anxiety and Depression Scale (Both subscales will be assessed. Scores on each subscale range from 0-8, which higher scores indicating either more anxiety or more depression).

Secondary Outcome Measures

Change in self-referential affect
Average self-reported emotion intensity using Likert-style scales ranging from 1-5 during the Karaoke task, in which higher scores represent greater emotional intensity.
Frontolimbic emotional reactivity circuit activity
fMRI activity in the frontolimbic emotional reactivity circuit activity for the own-singing v. professional-singing contrast during the Karaoke task
Acute change in slow-wave sleep (minutes)
Change in minutes of time in slow-wave sleep
Chronic change in slow-wave sleep (minutes)
Change in minutes of time in slow-wave sleep
Acute change in slow-wave sleep (%)
Change in percent of time in slow-wave sleep
Chronic change in slow-wave sleep (%)
Change in percent of time in slow-wave sleep
Acute change in total sleep time
Change in minutes asleep
Chronic change in total sleep time
Change in minutes asleep
Acute change in sleep efficiency
Change in proportion of time in bed spent asleep
Chronic change in sleep efficiency
Change in proportion of time in bed spent asleep
Acute change in wake after sleep onset
Change in minutes awake after sleep onset
Chronic change in wake after sleep onset
Change in minutes awake after sleep onset
Acute change in sleep latency
Change in minutes until sleep onset
Chronic change in sleep latency
Change in minutes until sleep onset
Change in X-probe d'
Change in the standardized hit rate for AX trials minus the standardized false alarm rate to BX trials on the modified AX-CPT task
Change in B-cue d'
Change in the standardized hit rate for BY trials minus the standardized false alarm rate to AX trials on the modified AX-CPT task
Change in Y-probe d'
Change in the standardized hit rate for BY trials minus the standardized false alarm rate to AY trials on the modified AX-CPT task
Change in vigilant attention d'
Change in the standardized hit rate for AX trials minus the standardized false alarm rate to CD trials on the modified AX-CPT task

Full Information

First Posted
March 13, 2023
Last Updated
October 4, 2023
Sponsor
Michelle Stepan
Collaborators
National Institute of Mental Health (NIMH), Brain & Behavior Research Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT05802004
Brief Title
Acoustic Stimulation, Sleep, and Cognitive-Emotional Processes in Young Adults With Anxiety and Depression Symptoms
Acronym
SERS
Official Title
The Effect of Acoustic Enhancement of Slow-Wave Activity on Cognitive Control and Emotional Reactivity in Young Adults With Anxiety and Depression Symptoms
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
December 2023 (Anticipated)
Primary Completion Date
March 2027 (Anticipated)
Study Completion Date
March 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Michelle Stepan
Collaborators
National Institute of Mental Health (NIMH), Brain & Behavior Research Foundation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes

5. Study Description

Brief Summary
In this study, the investigators will recruit young adults (ages 18-25 years) with elevated anxiety/depression symptoms and sleep disturbance. Participants will complete two overnights in a sleep lab. During one of the overnights, slow-wave activity will be enhanced by delivering sub-arousal auditory tones during slow-wave sleep using the Dreem 2 Headband device. During the other overnight, tones will not be administered. Cognitive and emotional processes will be evaluated using behavioral task performance, self-report, and functional magnetic resonance imaging (fMRI). After the second overnight, participants will take the headband device home and wear it every night for approximately 2 weeks. For half of the participants, the headband will play tones every night and, for the other half, the headband will not play tones. Participants will then return for a final testing visit in which cognitive and emotional processes and anxiety/depression symptoms will be assessed using behavioral task performance and self-report.
Detailed Description
When interested participants are identified through recruitment methods, they will be directed to complete an online screening survey. The aim of this screening is to ensure that participants meet minimal study inclusion/exclusion criteria and to avoid an unnecessary in-person visit to the lab. Based on the online screening, eligible participants will be contacted by study personnel for scheduling for the in-lab baseline visit. During the baseline visit, informed consent will be obtained. The investigators will also perform additional screening, a hearing test, and an audio recording of the participant singing in preparation for the karaoke task (described below). Finally, participants will be given a sleep diary and a wrist actigraphy device with which to track their sleep at home for at least 1-week before each overnight session. Participants will be told to maintain a consistent sleep schedule (+/- 1hr around wake and bedtimes) for at least one week. Sleep diary and actigraphy will be used to verify compliance. Participants will also be asked to refrain from alcohol and recreational drug use for 48hrs before each in-lab overnight session and will be asked to refrain from consuming caffeine after Noon on the day of their overnight visits. Approximately 1-2 weeks later, participants will return for their first overnight visit. They will be screened for drug/alcohol use through a subjective questionnaire. Prior to sleep, participants will complete a set of tasks and questionnaires assessing mood, sleepiness, cognition, and emotional processing. The primary tasks will include a modified AX-CPT cognitive control task and a karaoke task. After completing these tasks, participants will be randomized in counterbalanced order to receive acoustic stimulation during sleep (STIM) or a control night with no acoustic stimulation (SHAM). Participants will remain blind to condition. During STIM, participants will wear the Dreem 2 Headband, which presents sub-arousal tones during slow-wave sleep to boost underlying slow-wave activity. During SHAM, participants will wear the same device, but no tones will be administered. During both nights, participants will also be set up with standard polysomnography to objectively assess sleep and slow-wave activity. Post-sleep, participants will again complete a set of tasks and questionnaires assessing mood, sleepiness, cognition, and emotional processing. The primary tasks will include a modified AX-CPT task, an International Affective Picture Stimuli (IAPS) task, and the Karaoke task which will be competed in an fMRI scanner. After a 1-2-week washout period at home, participants will return for their second overnight session to complete the other experimental condition. For at least one week before the second overnight, participants will maintain a consistent sleep schedule (+/- 1hr around wake and bedtimes), verified with wrist actigraphy and sleep diary. Participants will again be asked to refrain from alcohol and recreational drugs use for 48hrs before the overnight session and will be asked to refrain from consuming caffeine after Noon on the day of their overnight visit. After completing the second overnight session, participants will take a headband device home and wear it each night for approximately 2 weeks. Participants will be asked to maintain a consistent sleep schedule (+/- 1hr around wake and bedtimes). Half of the participants will be randomly assigned to receive tones each night (Stim2) and half will not (Sham2). Participant will be blind to condition. Participants will complete daily assessments of their mood, anxiety/depression symptoms, and sleep quality. After the ~2 weeks at home, participants will return for a final testing visit. Participants will complete assessments of their mood, anxiety/depression symptoms, cognition, and emotional processing. Below is a description of the primary tasks: AX-CPT task: participants view cue-probe pairings, displayed as two letters presented one at a time on a computer screen. The first letter is the cue and the second letter is the probe. Participants are instructed to press a button when they encounter the valid cue-probe pairing and a different button for non-valid cue-probe pairings. IAPS task: participants will be presented with neutral and negative images from the International Affective Picture System. Participants may be asked to rate their affect, valence, and arousal after each image. Karaoke task: this task is intended to assess emotional processes, particularly self-referential emotions (i.e., shame, embarrassment). During the baseline visit, participants will sing while being audio recorded. Participants may be asked to wear headphones, which will present the song audio, but will mask their own singing, to promote out-of-tune singing. During the overnight visits, participants will listen to audio snips of their own singing and the same song sung by a professional singer. Participants will rate the intensity of different emotions.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acoustic Stimulation
Keywords
Acoustic stimulation, Slow-wave activity, Anxiety, Depression, Cognitive control, Emotion, Daily acoustic stimulation

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
This is a randomized, within-subjects, crossover design with two conditions: acoustic stimulation (STIM) and no acoustic stimulation (SHAM), followed by an at-home randomized, between-subjects design with two conditions: daily acoustic stimulation (STIM2) or no daily acoustic stimulation (SHAM2).
Masking
Participant
Masking Description
The sleep techs who will score the sleep record and the fMRI personnel conducting the scanning sessions will also be masked.
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Stim, then Sham, then daily Stim
Arm Type
Experimental
Arm Description
For the 2 overnights in the sleep lab, this arm will be randomized to complete acoustic stimulation (STIM) on the first overnight and no acoustic stimulation (SHAM) on the second overnight and then daily acoustic stimulation (STIM2) during the ~2 weeks at-home.
Arm Title
Stim, then Sham, then daily Sham
Arm Type
Experimental
Arm Description
For the 2 overnights in the sleep lab, this arm will be randomized to complete acoustic stimulation (STIM) on the first overnight and no acoustic stimulation (SHAM) on the second overnight and then no daily acoustic stimulation (SHAM2) during the ~2 weeks at-home.
Arm Title
Sham, then Stim, then daily Stim
Arm Type
Experimental
Arm Description
For the 2 overnights in the sleep lab, this arm will be randomized to complete no acoustic stimulation (SHAM) on the first overnight and acoustic stimulation (STIM) on the second overnight and then daily acoustic stimulation (STIM2) during the ~2 weeks at-home.
Arm Title
Sham, then Stim, then daily Sham
Arm Type
Experimental
Arm Description
For the 2 overnights in the sleep lab, this arm will be randomized to complete no acoustic stimulation (SHAM) on the first overnight and acoustic stimulation (STIM) on the second overnight and then no daily acoustic stimulation (SHAM2) during the ~2 weeks at-home.
Intervention Type
Device
Intervention Name(s)
Acoustic Stimulation (STIM)
Other Intervention Name(s)
Dreem 2 Headband
Intervention Description
During the in-lab overnight, the Dreem 2 Headband will be used to administer acoustic stimulation. Tones will be played during slow-wave sleep to enhance underlying slow-wave activity (0.5 - 4 Hz delta spectral power). Tones are phase-locked to the up-phase of the delta wave. Tone delivery is paused when an arousal is detected.
Intervention Type
Device
Intervention Name(s)
No Acoustic Stimulation (SHAM)
Other Intervention Name(s)
Dreem 2 Headband
Intervention Description
During the in-lab overnight, the participant will wear the Dreem 2 Headband, but the device will not administer acoustic stimulation. The device will be on and will still monitor sleep, but will not play tones.
Intervention Type
Device
Intervention Name(s)
Daily acoustic stimulation (STIM2)
Other Intervention Name(s)
Dreem 2 Headband
Intervention Description
During the ~2 weeks at home, the Dreem 2 Headband will be used to administer acoustic stimulation. Tones will be played during slow-wave sleep to enhance underlying slow-wave activity (0.5 - 4 Hz delta spectral power). Tones are phase-locked to the up-phase of the delta wave. Tone delivery is paused when an arousal is detected.
Intervention Type
Device
Intervention Name(s)
No daily acoustic stimulation (SHAM2)
Other Intervention Name(s)
Dreem 2 Headband
Intervention Description
During the ~2 weeks at home, the participant will wear the Dreem 2 Headband, but the device will not administer acoustic stimulation. The device will be on and will still monitor sleep, but will not play tones.
Primary Outcome Measure Information:
Title
Acute change in slow-wave activity
Description
Change in 0.5 - 4 Hz delta spectral power
Time Frame
Change from the Sham overnight to the Stim overnight
Title
Slow-wave activity (chronic change)
Description
0.5 - 4 Hz delta spectral power
Time Frame
Assessed daily during the ~2 weeks at home
Title
Change in top-down attention d'
Description
Change in the standardized hit rate for AX trials minus the standardized false alarm rate to AY trials on the modified AX-CPT task
Time Frame
Change across the Sham overnight, the Stim overnight, and the final testing visit
Title
Change in cognitive flexibility d'
Description
Change in the standardized hit rate for BY trials minus the standardized false alarm rate to AX trials on the modified AX-CPT task
Time Frame
Change across the Sham overnight, the Stim overnight, and the final testing visit
Title
Change in frontoparietal cognitive control circuit activity
Description
Change in fMRI activity in the frontoparietal cognitive control circuit activity (e.g., dorsolateral prefrontal cortex, inferior parietal lobule, middle cingulate gyrus, precuneus) for the AX v. AY contrast during the modified AX-CPT task
Time Frame
Change from the Sham overnight to the Stim overnight
Title
Change in frontoparietal cognitive control circuit activity
Description
Change in fMRI activity in the frontoparietal cognitive control circuit activity (e.g., dorsolateral prefrontal cortex, inferior parietal lobule, middle cingulate gyrus, precuneus) for the BY v. AX contrast during the modified AX-CPT task
Time Frame
Change from the Sham overnight to the Stim overnight
Title
Change in negative affect
Description
Change in average self-reported negative affect using Likert-style scales during the International Affective Picture Stimuli task. Scales will range from 1-100, with higher scores representing more negative affect.
Time Frame
Change across the Sham overnight, the Stim overnight, and the final testing visit
Title
Change in frontolimbic emotional reactivity circuit activity
Description
Change in fMRI activity in the frontolimbic emotional reactivity circuit activity for the negative v. neutral image contrast during the International Affective Picture Stimuli task
Time Frame
Change from the Sham overnight to the Stim overnight
Title
Change in anxiety symptoms
Description
Change in self-reported anxiety using the PROMIS anxiety scale (T-scores range from 36.3-82.7, with higher scores indicating worse anxiety symptoms)
Time Frame
Change across screening, the Sham overnight, the Stim overnight, and the final testing visit
Title
Change in depression symptoms
Description
Change in self-reported depression using the PROMIS depression scale (T-scores range from 37.1-81.1, with higher scores indicating worse depression symptoms)
Time Frame
Change across screening, the Sham overnight, the Stim overnight, and the final testing visit
Title
Change in mood
Description
Change in self-reported mood on the Daytime Insomnia Symptom Scale. All 20 subscales will be assessed and each subscale score ranges from 1-100, with higher scores indicating more of that mood (i.e., alert, sad, tense, effort, happy, weary, calm, sleep, overall mood, clear-headed, fatigued, anxious, exhausted, relaxed, forgetful, efficient, stressed, energetic, irritable, ability to concentrate).
Time Frame
Change across the ~2 weeks at home
Title
Change in anxiety/depression symptoms
Description
Change in self-reported anxiety and depression using the Anxiety and Depression Scale (Both subscales will be assessed. Scores on each subscale range from 0-8, which higher scores indicating either more anxiety or more depression).
Time Frame
Change across the ~2 weeks at home
Secondary Outcome Measure Information:
Title
Change in self-referential affect
Description
Average self-reported emotion intensity using Likert-style scales ranging from 1-5 during the Karaoke task, in which higher scores represent greater emotional intensity.
Time Frame
Change from the Sham overnight to the Stim overnight
Title
Frontolimbic emotional reactivity circuit activity
Description
fMRI activity in the frontolimbic emotional reactivity circuit activity for the own-singing v. professional-singing contrast during the Karaoke task
Time Frame
Change from the Sham overnight to the Stim overnight
Title
Acute change in slow-wave sleep (minutes)
Description
Change in minutes of time in slow-wave sleep
Time Frame
Change from the Sham overnight to the Stim overnight
Title
Chronic change in slow-wave sleep (minutes)
Description
Change in minutes of time in slow-wave sleep
Time Frame
Change across the ~2 weeks at home
Title
Acute change in slow-wave sleep (%)
Description
Change in percent of time in slow-wave sleep
Time Frame
Change from the Sham overnight to the Stim overnight
Title
Chronic change in slow-wave sleep (%)
Description
Change in percent of time in slow-wave sleep
Time Frame
Change across the ~2 weeks at home
Title
Acute change in total sleep time
Description
Change in minutes asleep
Time Frame
Change from the Sham overnight to the Stim overnight
Title
Chronic change in total sleep time
Description
Change in minutes asleep
Time Frame
Change across the ~2 weeks at home
Title
Acute change in sleep efficiency
Description
Change in proportion of time in bed spent asleep
Time Frame
Change from the Sham overnight to the Stim overnight
Title
Chronic change in sleep efficiency
Description
Change in proportion of time in bed spent asleep
Time Frame
Change across the ~2 weeks at home
Title
Acute change in wake after sleep onset
Description
Change in minutes awake after sleep onset
Time Frame
Change from the Sham overnight to the Stim overnight
Title
Chronic change in wake after sleep onset
Description
Change in minutes awake after sleep onset
Time Frame
Change across the ~2 weeks at home
Title
Acute change in sleep latency
Description
Change in minutes until sleep onset
Time Frame
Change from the Sham overnight to the Stim overnight
Title
Chronic change in sleep latency
Description
Change in minutes until sleep onset
Time Frame
Change across the ~2 weeks at home
Title
Change in X-probe d'
Description
Change in the standardized hit rate for AX trials minus the standardized false alarm rate to BX trials on the modified AX-CPT task
Time Frame
Change across the Sham overnight, the Stim overnight, and the final testing visit
Title
Change in B-cue d'
Description
Change in the standardized hit rate for BY trials minus the standardized false alarm rate to AX trials on the modified AX-CPT task
Time Frame
Change across the Sham overnight, the Stim overnight, and the final testing visit
Title
Change in Y-probe d'
Description
Change in the standardized hit rate for BY trials minus the standardized false alarm rate to AY trials on the modified AX-CPT task
Time Frame
Change across the Sham overnight, the Stim overnight, and the final testing visit
Title
Change in vigilant attention d'
Description
Change in the standardized hit rate for AX trials minus the standardized false alarm rate to CD trials on the modified AX-CPT task
Time Frame
Change across the Sham overnight, the Stim overnight, and the final testing visit

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
25 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 18-25. Equal numbers of men and women will be included. Normal hearing. Elevated anxiety or depression symptoms. This will be determined using the PROMIS anxiety and PROMIS depression scales. Participants with T-scores ≥ 60 (i.e., ≥ than 1 standard deviation above the mean) on either or both scales will be eligible for participation. Elevated sleep disturbance. This will be determined using the PROMIS sleep disturbance scale. Participants with T-scores ≥ 55 on the PROMIS sleep disturbance scale will be eligible for participation. Exclusion Criteria: Presence of a severe chronic or psychiatric condition including psychosis, bipolar disorder, developmental disorders, or substance use disorder. Current use of psychotropic medications or medications affecting sleep/wake function, such as antidepressants, antipsychotic medications, steroids, and stimulants. Rationale: These medications may affect sleep and cognitive-emotional function. Substance abuse. Rationale: Substance abuse may affect sleep and cognitive-emotional function. Consumption of > 14 standard alcoholic drinks per week. Rationale: excessive alcohol consumption may interfere with sleep and cognitive-emotional function. Consumption of > 400mg of caffeine per day, which is roughly equivalent to 3-4 8oz cups of coffee per day. Drug or alcohol use < 48 hours before the in-lab overnight sessions. Rationale: Recent drug or alcohol use could affect sleep, cognitive-emotional processes, and poses a safety risk. Severe insomnia or sleep apnea symptoms. Insomnia symptoms will be determined using the Insomnia Severity Index. Participants with severe insomnia (i.e., scores > 21) will not be eligible. Sleep apnea symptoms will be determined using the STOP-Bang questionnaire. Participants with scores ≥ 3 will not be eligible. Rationale: Sleep disturbances which result in low sleep efficiency and frequent awakenings during the night may reduce the effectiveness of acoustic stimulation which targets the deepest stage of sleep (i.e., slow-wave sleep). Extreme bedtimes (< 10:00pm, > 1:00am) or wake times (< 6:00am, > 10:00am). Rationale: Participants with extreme bed or wake times may have difficulty falling asleep, waking up, or obtaining a sufficient amount of sleep during the in-lab overnight sessions. Short (<5hrs) or long (>9hrs) average sleep duration. Rationale: short or long sleepers may have different sleep profiles which could impact the effectiveness of the acoustic stimulation intervention. Uncorrected vision problems. Claustrophobia. Rationale: MRI safety criteria. Metal in body. Rationale: MRI safety criteria. Body Mass Index (BMI) > 40. Rationale: MRI safety criteria. Pregnancy. Rationale: MRI safety criteria. Left handedness. Rationale: Left-handed people may have different lateralization of neural functioning which could affect the fMRI results. Formal vocal training. Rationale: The purpose of the karaoke task is to induce negative self-referential emotions via out-of-tune singing. Good at singing in tune. Rationale: The purpose of the karaoke task is to induce negative self-referential emotions, therefore participants who are good at singing in tune will be excluded. Does not own a smartphone or tablet. Rationale: participants will need to download the Alfin app to download their sleep data from the Dreem 2 headband when wearing the headband at home. Inability or unwillingness to complete study procedures.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Michelle E Stepan, PhD
Phone
7247570761
Email
stepanme@upmc.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michelle E Stepan, PhD
Organizational Affiliation
University of Pittsburgh
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Pittsburgh
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Michelle E Stepan, PhD
Phone
724-757-0761
Email
stepanme@upmc.edu

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
De-identified IPD associated with publications will be made available to researchers upon reasonable request. IPD will also be stored in a central data repository at the University of Pittsburgh, which can be accessed by researchers at the institution who have appropriate qualifications and access information. Examples of IPD that can be shared with other researchers include descriptive data such as means and de-identified performance scores on cognitive and emotional tasks, self-reports of mood or anxiety/depression symptoms, summarized sleep EEG data, and summarized fMRI data.
IPD Sharing Time Frame
Data will become available once data collection is finalized. IPD associated with manuscripts will become available once the manuscript is published.
IPD Sharing Access Criteria
To access the data, the requester must have completed and up-to-date research and ethics training and data use or material transfer agreements must be in place.

Learn more about this trial

Acoustic Stimulation, Sleep, and Cognitive-Emotional Processes in Young Adults With Anxiety and Depression Symptoms

We'll reach out to this number within 24 hrs